CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the pricing of an underwritten public offering of 15,307,000 shares of its common stock, at a price to the public of $19.60 per share. …
JOHN Howard led the country, Maroon 5 topped the ARIA charts with She Will Be Loved and Tim Sullivan ... Josh O'Leary came away with the spoils in the best …
BioLife Solutions (NASDAQ: BLFS) 48.2% HIGHER; announced that its customer TiGenix NV, an advanced …
Ariad Pharamceuticals ($ARIA) is breaking out. The chart above shows the stock started higher out of a wedge in February with a slow trend higher to a peak in early June. A short pullback to a higher low in late June then saw a steep …
Alunbrig (brigatinib); Ariad Pharmaceuticals; For the treatment of advanced ALK …
This braised oxtail, for example, uses far less stock than I’d usually use if I was cooking it ... Matt Moran is co …
Former Democratic presidential candidate Bernie Sanders and U.S. Representative Elijah Cummings issued a letter on …
Ned Pagliarulo/BioPharma Dive, market data Japanese pharma Takeda Pharmaceutical Company, for example, paid $24 a share to acquire Ariad Pharmaceuticals, Inc and its cancer drugs in January — a 75% premium to the company’s …